Substituted pyrrolizine compounds as HBV replication inhibitors

This application relates generally to certain substituted pyrrolizine compounds, and pharmaceutical compositions which inhibit HBV replication, and methods of making and using them.

Saved in:
Bibliographic Details
Main Authors LAZERWITH, Scott E, GUTIERREZ, David Alan, MORGANELLI, Philip Anthony, LEE, Rick Andrew, PYUN, Hyung-Jung, KOBAYASHI, Tetsuya
Format Patent
LanguageEnglish
Published 27.08.2020
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:This application relates generally to certain substituted pyrrolizine compounds, and pharmaceutical compositions which inhibit HBV replication, and methods of making and using them.
Bibliography:Application Number: AU20190223182